Laboratorios Farmaceuticos Rovi, S.A. 41L.F Stock
Laboratorios Farmaceuticos Rovi, S.A. Price Chart
Laboratorios Farmaceuticos Rovi, S.A. 41L.F Financial and Trading Overview
| Laboratorios Farmaceuticos Rovi, S.A. stock price | 83.1 EUR |
| Previous Close | 42.88 EUR |
| Open | 42.36 EUR |
| Bid | 42.36 EUR x 16100 |
| Ask | 42.48 EUR x 15600 |
| Day's Range | 42.36 - 42.46 EUR |
| 52 Week Range | 35.5 - 60.85 EUR |
| Volume | 2 EUR |
| Avg. Volume | 22 EUR |
| Market Cap | 2.22B EUR |
| Beta (5Y Monthly) | 0.44521 |
| PE Ratio (TTM) | 11.794444 |
| EPS (TTM) | 3.2 EUR |
| Forward Dividend & Yield | 1.29 (2.95%) |
| Ex-Dividend Date | July 3, 2023 |
| 1y Target Est | N/A |
41L.F Valuation Measures
| Enterprise Value | 2.23B EUR |
| Trailing P/E | 11.794444 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 2.7324064 |
| Price/Book (mrq) | 3.9951072 |
| Enterprise Value/Revenue | 2.744 |
| Enterprise Value/EBITDA | 8.458 |
Trading Information
Laboratorios Farmaceuticos Rovi, S.A. Stock Price History
| Beta (5Y Monthly) | 0.44521 |
| 52-Week Change | -21.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 60.85 EUR |
| 52 Week Low | 35.5 EUR |
| 50-Day Moving Average | 41.37 EUR |
| 200-Day Moving Average | 40.87 EUR |
41L.F Share Statistics
| Avg. Volume (3 month) | 22 EUR |
| Avg. Daily Volume (10-Days) | 20 EUR |
| Shares Outstanding | 52.37M |
| Float | 20.83M |
| Short Ratio | N/A |
| % Held by Insiders | 60.25% |
| % Held by Institutions | 18.32% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 1.294 |
| Trailing Annual Dividend Yield | 3.01% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.2616 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 23.84% |
| Operating Margin (ttm) | 30.25% |
| Gross Margin | 63.13% |
| EBITDA Margin | 32.44% |
Management Effectiveness
| Return on Assets (ttm) | 18.87% |
| Return on Equity (ttm) | 39.02% |
Income Statement
| Revenue (ttm) | 813.75M EUR |
| Revenue Per Share (ttm) | 15.25 EUR |
| Quarterly Revenue Growth (yoy) | -1.89% |
| Gross Profit (ttm) | 512.43M EUR |
| EBITDA | 264.01M EUR |
| Net Income Avi to Common (ttm) | 194.08M EUR |
| Diluted EPS (ttm) | 3.6 |
| Quarterly Earnings Growth (yoy) | -10.50% |
Balance Sheet
| Total Cash (mrq) | 141.46M EUR |
| Total Cash Per Share (mrq) | 2.65 EUR |
| Total Debt (mrq) | 69.31M EUR |
| Total Debt/Equity (mrq) | 12.18 EUR |
| Current Ratio (mrq) | 2.473 |
| Book Value Per Share (mrq) | 10.628 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 158M EUR |
| Levered Free Cash Flow (ttm) | 52.89M EUR |
Profile of Laboratorios Farmaceuticos Rovi, S.A.
| Country | Germany |
| State | N/A |
| City | Madrid |
| Address | Calle José Isbert, 2 |
| ZIP | 28223 |
| Phone | 34 91 021 30 00 |
| Website | https://www.rovi.es |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1993 |
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa. It provides non-prescription pharmaceutical products; and contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, hard capsules, and sachets. The company was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
Q&A For Laboratorios Farmaceuticos Rovi, S.A. Stock
What is a current 41L.F stock price?
Laboratorios Farmaceuticos Rovi, S.A. 41L.F stock price today per share is 83.1 EUR.
How to purchase Laboratorios Farmaceuticos Rovi, S.A. stock?
You can buy 41L.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Laboratorios Farmaceuticos Rovi, S.A.?
The stock symbol or ticker of Laboratorios Farmaceuticos Rovi, S.A. is 41L.F.
Which industry does the Laboratorios Farmaceuticos Rovi, S.A. company belong to?
The Laboratorios Farmaceuticos Rovi, S.A. industry is Biotechnology.
How many shares does Laboratorios Farmaceuticos Rovi, S.A. have in circulation?
The max supply of Laboratorios Farmaceuticos Rovi, S.A. shares is 51.25M.
What is Laboratorios Farmaceuticos Rovi, S.A. Price to Earnings Ratio (PE Ratio)?
Laboratorios Farmaceuticos Rovi, S.A. PE Ratio is 25.96875000 now.
What was Laboratorios Farmaceuticos Rovi, S.A. earnings per share over the trailing 12 months (TTM)?
Laboratorios Farmaceuticos Rovi, S.A. EPS is 3.2 EUR over the trailing 12 months.
Which sector does the Laboratorios Farmaceuticos Rovi, S.A. company belong to?
The Laboratorios Farmaceuticos Rovi, S.A. sector is Healthcare.